MONIQUE TORRES: Open Payments
NPI 1922562834 · LILLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,730 in 98 payments from 31 companies in 2025. Trend: 2023 $2,116 · 2024 $2,040 · 2025 $1,730
Food & beverage: $1,730
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $187 |
| ABBVIE INC. | 10 | $176 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| Exact Sciences Corporation | 10 | $135 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| Novo Nordisk Inc | 4 | $104 |
| Corcept Therapeutics | 5 | $96 |
| Kowa Pharmaceuticals America, Inc. | 4 | $65 |
| PFIZER INC. | 3 | $58 |
| TOLMAR, INC. | 3 | $56 |
Products named: OTEZLA, VRAYLAR, XIFAXAN, Korlym, Cologuard Collection Kit, Wegovy, FARXIGA, BREZTRI.
Industry payments across NC — which companies pay providers there.
